We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

208 hedge funds and large institutions have $1.18B invested in Immunogen Inc in 2018 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 61 increasing their positions, 61 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

660% more call options, than puts

Call options by funds: $16.9M | Put options by funds: $2.22M

37% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 27

5% more funds holding

Funds holding: 198 → 208 (+10)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 61

3% less capital invested

Capital invested by funds: $1.22B → $1.18B (-$41.6M)

Holders
208
Holders Change
+10
Holders Change %
+5.05%
% of All Funds
4.76%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
37
Increased
61
Reduced
61
Closed
27
Calls
$16.9M
Puts
$2.22M
Net Calls
+$14.6M
Net Calls Change
+$14.6M

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$39.6M
2
ACH
ArrowMark Colorado Holdings
Colorado
+$18.5M
3
BlackRock
BlackRock
New York
+$10.1M
4
BNP Paribas Asset Management
BNP Paribas Asset Management
France
+$9.02M
5
Millennium Management
Millennium Management
New York
+$5.57M

Top Sellers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
-$22.5M
2
Franklin Resources
Franklin Resources
California
-$16.9M
3
O
OrbiMed
New York
-$13.8M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$11.6M
5
ClearBridge Investments
ClearBridge Investments
New York
-$10.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
SWP
176
Stratos Wealth Partners
Ohio
$4K +$4.54K +472 New
FHA
177
Flagship Harbor Advisors
Massachusetts
$3K – – –
FIA
178
FNY Investment Advisers
New York
$3K – – –
RFA
179
Reilly Financial Advisors
California
$3K +$144 +15 +5%
DWA
180
Dorsey Wright & Associates
California
$3K +$2.93K +305 New
AssetMark Inc
181
AssetMark Inc
California
$2K – – –
CAW
182
Cornerstone Advisors (Washington)
Washington
$2K – – –
PNC Financial Services Group
183
PNC Financial Services Group
Pennsylvania
$2K – – –
TC
184
Trilogy Capital
California
$2K – – –
HNB
185
Huntington National Bank
Ohio
$2K +$10 +1 +0.5%
GRP
186
Global Retirement Partners
California
$2K +$183 +19 +9%
S
187
SignatureFD
Georgia
$2K +$250 +26 +16%
CHP
188
Cable Hill Partners
Oregon
$1K -$4.03K -419 -73%
TFS
189
TrustCore Financial Services
Tennessee
$1K -$1.01K -105 -62%
HMS
190
Hanseatic Management Services
New Mexico
$1K -$750 -78 -44%
CFA
191
Carroll Financial Associates
North Carolina
$1K -$10 -1 -0.5%
FWM
192
Focused Wealth Management
New York
$1K – – –
GWM
193
Geneos Wealth Management
Colorado
$1K – – –
SIM
194
Sonora Investment Management
Arizona
$1K – – –
AC
195
Avestar Capital
New York
$1K +$231 +24 +2%
BBHC
196
Brown Brothers Harriman & Co
New York
$1K +$1.35K +141 New
BA
197
Ballew Advisors
Mississippi
$1K +$1.92K +200 New
APA
198
American Portfolios Advisors
New York
$474 – – –
RCAG
199
Rehmann Capital Advisory Group
Michigan
$454 – – –
TPWA
200
TRUE Private Wealth Advisors
Oregon
$426 +$433 +45 New
6 7
8
9 10

IMGN Hedge Fund Activity: Q3 2018 in Review

208 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q3 2018, worth a combined $1.18B — down 3.4% from $1.22B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new IMGN positions and 27 closed out — a net gain of 10 holders — while 61 added to existing stakes and 61 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $39.6M. The largest seller was Capital Research Global Investors, cutting an estimated $22.5M.

  • 208 institutional investors held Immunogen Inc (IMGN) as of Q3 2018, up from 198 in Q2 2018.
  • Funds reported $1.18B of Immunogen Inc stock for Q3 2018, down 3.4% quarter-over-quarter.
  • 37 funds opened new Immunogen Inc positions in Q3 2018 and 27 closed out, a net change of +10 holders.
  • The largest Immunogen Inc buyer in Q3 2018 was Point72 Asset Management, an estimated $39.6M added.
  • The largest Immunogen Inc seller in Q3 2018 was Capital Research Global Investors, an estimated $22.5M sold.

Based on aggregated 13F filings for Q3 2018.